{"id":297920,"date":"2019-10-11T22:00:10","date_gmt":"2019-10-12T05:00:10","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/10\/harbour-biomed-completes-china-phase-ii-trial-of-dry-eye-treatment\/"},"modified":"2019-10-11T22:02:40","modified_gmt":"2019-10-12T05:02:40","slug":"%e5%92%8c%e9%89%91%e9%86%ab%e8%97%a5%e5%ae%8c%e6%88%90%e4%b8%ad%e5%9c%8b%e5%b9%b9%e7%9c%bc%e7%99%a5%e6%b2%bb%e7%99%82%e4%ba%8c%e6%9c%9f%e8%a9%a6%e9%a9%97","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/10\/%e5%92%8c%e9%89%91%e9%86%ab%e8%97%a5%e5%ae%8c%e6%88%90%e4%b8%ad%e5%9c%8b%e5%b9%b9%e7%9c%bc%e7%99%a5%e6%b2%bb%e7%99%82%e4%ba%8c%e6%9c%9f%e8%a9%a6%e9%a9%97\/","title":{"rendered":"\u548c\u9251\u91ab\u85e5\u5b8c\u6210\u4e2d\u570b\u5e79\u773c\u7665\u6cbb\u7642\u4e8c\u671f\u8a66\u9a57"},"content":{"rendered":"<p>\u548c\u9251\u91ab\u85e5\u5b8c\u6210\u4e86HBM9036\uff08tanfanercept\uff09\u5728\u4e2d\u570b\u7684\u4e8c\u671f\u81e8\u5e8a\u8a66\u9a57\uff0cHBM9036\u662f\u4e00\u7a2e\u65b0\u7684TNF\u53d7\u9ad41\u7247\u6bb5\uff0c\u9069\u7528\u65bc\u4e2d\u5ea6\u81f3\u91cd\u5ea6\u5e79\u773c\u75c5\u3002 2017\u5e74\uff0c\u548c\u9251\u91ab\u85e5\u5f9e\u97d3\u570bHanAll\u7372\u5f97\u4e86HBM9036\u7684\u5c08\u5229\u6b0a\uff0c\u5176\u4e2d\u9084\u5305\u62ec\u91dd\u5c0d\u75c5\u539f\u6027IgG\u4ecb\u5c0e\u7684\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u7684\u7642\u6cd5\u3002\u548c\u9251\u91ab\u85e5\u6307\u51fa\uff0c\u8655\u65b9\u5e79\u773c\u85e5\u6c34\u53ef\u7de9\u89e3\u5e79\u773c\u7665\u7665\u72c0\uff0c\u4f46\u4e0d\u80fd\u89e3\u6c7a\u6f5b\u5728\u7684\u708e\u7665\u3002\u548c\u9251\u91ab\u85e5\u7e3d\u90e8\u4f4d\u65bc\u6ce2\u58eb\u9813\uff0c\u5728\u8377\u862d\u548c\u4e0a\u6d77\u8a2d\u6709\u696d\u52d9\u3002<\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aChina Biotoday<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Harbour BioMed (HBM) completed a China Phase II trial of HBM9036 (tanfanercept), a novel TNF receptor-1 fragment indicated for moderate-to-severe Dry-Eye-Disease. In 2017, Harbour in-licensed China rights to the candidate in a two-drug deal from Korea&#8217;s HanAll, which also included a treatment for pathogenic IgG-mediated autoimmune diseases.<\/p>\n","protected":false},"author":9,"featured_media":297914,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[426],"tags":[927,563,644,564],"class_list":["post-297920","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hant","tag-927","tag--zh-hant","tag-644","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant","locations-us-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/297920","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=297920"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/297920\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/297914"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=297920"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=297920"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=297920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}